NDC 0009-3381-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0009-3381
- Requested NDC
- 0009-3381-01
- Package NDCs from labels
- 0009-3381-01, 0009-3381-02
- Manufacturer
- Pharmacia & Upjohn Company LLC
- Effective date
- 2026-07-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Pharmacia & Upjohn Company LLC | Pharmacia & Upjohn Company LLC | 2026-07-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0009-3381-01 | Cleocin Phosphate | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 59 | |
| 0009-3381-02 | Cleocin Phosphate | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | 59 | |
| 0009-3381-02 | Cleocin Phosphate | 2 in 1 PACKAGE | INJECTION, SOLUTION | 2 | 59 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0009-3381 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION CLEOCIN PHOSPHATE (0009-6582) (STANDALONE) (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [PHARMACIA & UPJOHN COMPANY LLC] | 55 | Legacy NDC, 3 package rows | 20250406_05a75685-0af5-407c-ac57-e380c882b49d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0009-3381-01 | ML - Milliliter | 0009-3381 | a3cdd492-f8ae-416f-af2c-5175405f2a0d | 1 | 2013-06-04 |
| 0009-3381-02 | ML - Milliliter | 0009-3381 | 2d37d73c-6731-4a74-9798-d20bc1b97707 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE TOPICAL | Carnegie Pharmaceuticals, LLC | c8fe61f1-f3c5-4452-9980-a727461b9844 | 2025-12-15 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Mylan Pharmaceuticals Inc. | f7480256-8b32-419a-8983-e2c413040dba | 2025-12-12 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Alembic Pharmaceuticals Inc. | 96434354-a646-4869-92a2-4052d3f7a4aa | 2025-12-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Walgreen Anti Nausea Cherry Flavor | PHOSPHORATED CARBOHYDRATE | WALGREENS CO. | 69e72d30-feca-454d-addc-8ed7325568d3 | 2025-12-01 | Warnings | IY9XDZ35W2 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Padagis Israel Pharmaceuticals Ltd | e492d645-7d2e-4f8a-a43a-9999456e9f72 | 2025-11-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | A-S Medication Solutions | c205b9e8-3f62-4176-be4e-bc4b5dbf3893 | 2025-11-25 | Warnings, Adverse reactions | EH6D7113I8 |
| Cleocin T | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 4a3901a4-194f-4a15-9c85-3d0982afcf31 | 2025-11-24 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | A-S Medication Solutions | ba3f54e5-1ff5-4ffd-8ed2-f15439f423e9 | 2025-11-18 | Warnings, Adverse reactions | EH6D7113I8 |
| Anti Nausea Liquid | PHOSPHORATED CARBOHYDRATE | TOPCO ASSOCIATES LLC | fd0e8feb-89b5-42ff-806a-55b7473cf587 | 2025-11-10 | Warnings | IY9XDZ35W2 |
| AS-3 | AS-3 | GVS TM INC | 3dfa3397-fc13-4659-e063-6394a90a5abc | 2025-11-06 | Warnings | IY9XDZ35W2 |
| CP2D | CP2D | GVS TM INC | 3fa2e438-2ff0-a2df-e063-6394a90ac7b5 | 2025-11-06 | Warnings | IY9XDZ35W2 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 654477df-5cbb-491a-8aec-651598b76884 | 2025-10-24 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bryant Ranch Prepack | be216018-c30d-4184-9152-ae238e3edac4 | 2025-10-22 | Warnings, Adverse reactions | EH6D7113I8 |
| Sugar Cravings | CINNAMIC ACID, PHLORIDZINUM, ARGENTUM NITRICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, BEET SUGAR, DEXTROSE, D-RIBOSE, FRUCTOSE, LYCOPODIUM CLAVATUM, MAPLE SUGAR, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, MALVIN, ADRENOCORTICOTROPHIN, DYSENTERY BACILLUS, MORGAN GAERTNER | Dr. Donna Restivo DC | 401873ba-ae1b-4506-a2e8-c6c0e5ff27f5 | 2025-10-21 | Warnings | IY9XDZ35W2 |
| Clindamycin Phoaphate Topical Solution USP, 1% | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1% | Encube Ethicals, Inc. | b2dfb76b-db09-43e7-8366-6791449a4918 | 2025-09-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Chartwell RX, LLC | 7740ed35-ff93-4c5e-8983-934ff7b86da7 | 2025-09-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% | CLINDAMYCIN PHOSPHATE AND TRETINOIN GEL 1.2%/0.025% | Encube Ethicals, Inc. | 1f772408-52a3-45b2-b053-8fc78948983c | 2025-09-05 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Encube Ethicals, Inc. | 8ca01174-431e-449a-a85e-8c68d506776c | 2025-08-29 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Oceanside Pharmaceuticals | 1d53ec2b-d33d-4245-99f1-e41b30303660 | 2025-08-15 | Warnings, Adverse reactions | EH6D7113I8 |
| ONEXTON | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bausch Health US, LLC | 697e760a-c206-4565-8f4e-a8085e215827 | 2025-07-23 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.